Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
June 5, 2018
Susan Keown, of Fred Hutch News, released an article on June 4, 2018 highlighting the significant impact immunotherapy has had on MCC patients. Investigators, including Dr. Paul Nghiem, presented new, long-term data from clinical trials that showed how immunotherapy drugs have helped a significant subset of patients with this cancer survive much longer than would otherwise be possible. To read more, view the article here.